2 Follow-Up-Debriefing

BEMT Survey Follow-up Script and Debriefing Questions

OMB#0925-0589; Expiration Date: 4/30/2014

PRIVACY ACT NOTIFICATION STATEMENT

Collection of this information is authorized by The Public Health Service Act, Section 412 (42

USC 285 a-1). Rights of study participants are protected by The Privacy Act of 1974. Participation is voluntary, and there are no penalties for not participating or withdrawing from the study at any time. The information collected in this study will be kept in private under the Privacy Act. Names and other identifiers will be separated from information provided and will not appear in any report of the study. Information provided will be combined for all study participants and reported as summaries. You are being contacted initially by email to complete a survey so that we can clarify any responses to refine the features and functionality of the Biobank Economic Modeling Tool (BEMT). You may also be contacted by telephone to participate in brief follow-up to clarify your responses.

NOTIFICATION TO RESPONDENT OF ESTIMATED BURDEN

Public reporting burden for this collection of information is estimated to average thirty (30) minutes per respondent, including the time for reviewed instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions to reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0589). Do not return the completed form to this address.

Group: Respondents

Thank you for agreeing to participate in this debriefing interview. We’d like to ask you a few questions about your experience with the BEMT survey. Your thoughts are greatly appreciated and will help us to better understand the degree of difficulty, relevance of the information asked and perceived value of the survey, overall.

The feedback obtained will be reviewed but you will not be identified. Your comments will be kept strictly confidential under the Privacy Act.

Instructions to Interviewer: Please provide a copy of the relevant survey questions on pages 2-3 (list below) to the respondent for reference prior to debriefing. Please read each of the following questions on page 4 to the respondent. Fill in the answers on page 4.

Summary of BEMT Survey questions (only for reference during debriefing interview)

Section I: Biobank Demographics

• What is the total number of years your biobank has been in operation?

• In which country is your biobank headquarters located?

• In which geographic region is your biobank headquarters located?

• Are your biobank operations international?

• What is your biobank's operating model?

• How many operating sites does your biobank have?

• What is the total estimated size of your biobank facility?

• Does your biobank practice cost recovery?

Section II: Biobank Cost Recovery and Funding Considerations

• Approximately, what percentages (%) of your biobank expenses are recovered from provision of specimens, products and services?

• What is the percentage (%) contribution of each of the types of funds below to the overall funds brought in annually by the biobank?

• Of fees recovered annually by the biobank, what percentage (%) is contributed by each of the entity types below?

• Approximately, how much (USD) in total did your biobank spend on big-ticket item expenditures (e.g. equipment, informatics system, space planning & construction, furniture and furnishings) at start-up?

• Approximately, how much (USD) did your biobank spend on each of the following expenditures at start-up?

• Approximately, what is your total annual budget for operational expenditures (USD)?

• Approximately, how much does your biobank spend annually (USD) on the operational expenditures listed below?

• Approximately, what percentage (%) of your time do you allocate annually to performing the following activities for your biobank?

Section III: Biobank Cost and Pricing Consideration

• Estimated average annualized salary range (USD), fringe benefit percentage (%) and number of FTE's for employees your biobank budget supports

• What type of capital equipment do you currently have to support specimen collection and processing?

• What type of capital equipment do you currently have to support sample management and specimen storage?

• What type of capital equipment do you currently have to support specimen quality control and sample analysis?

Section IV: Biobank Specimens and Services

• Please provide details in the table below about specimens that your biobank offers to end users/customers. (This should include but may not be limited to anything listed on your biobank fee schedule/service menu.)

• Approximately, what do you charge (USD) per specimen for each of the sample testing related services below?

• Approximately, what do you charge (USD) per project for each of the biobanking project related services below?

• Approximately, what percentage (%) is your mark-up for provision of biospecimens?

• Approximately, what percentage (%) is your mark-up for specimen related services?

• Approximately, what percentage (%) is your overhead fee for external parties who use your biobank and/or collaborate on projects with your institution?

Section V: Additional question(s)

• Which best practice publications do you currently use to guide your biobank operations?

Biobank Economic Modeling Tool (BEMT) Survey Debriefing Questions

1a. What did you think of the degree of difficulty of the BEMT survey?

1b. For example, were there any specific sections you found you could not answer?

1c. Were there any questions for which you did not feel you were knowledgeable enough?

1d. Were there any questions you felt were out of scope of your area of job responsibility?

1e. Were there any other reasons you found the questions difficult?

1f. Which types of questions could you answer from memory to provide responses?

1g. Which types of questions did you need to refer to files and/or reference data to provide responses?

1h. Which types of questions did you need to consult with colleagues to provide responses?

2a. What types of data collected in the BEMT survey do you think would be most beneficial to your biobank?

2b. What makes this data valuable for your biobank?

2c. What was your perception of the value of providing this information vs. the time and effort to provide it?

4